Clinical Trial to Monitor the Efficacy of the Elosan Treatment by Applying Electrostatic
CompletedNCT04818294
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The Treatment Cabin 'Elosan cabin' is a closed, electrically insulated cabin for the short-term application of a high electrostatic voltage to the body of patients with chronic pain. Patients assigned will have 8 sessions in the treatment cabin, with an interval of 6 days between sessions. The existing therapies and painkillers will be continued at the discretion of the doctor.
Study details
- Official title
- Prospective, Multi-center, Clinical Trial (Phase IV Study) to Monitor the Efficacy of Treatment by Applying a High Electrostatic Charge to Patients With Chronic Pain, in the Practice of Clinical or Out-patient Pain Treatment Facilities.
- Conditions
- Interventions
- Device: Pain treatment by electrostatic charge to the whole body
- Sponsor
- Elosan AG
- Start date
- 2021-03-16
- Primary completion
- 2022-05-15
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Switzerland
- Total sites listed
- 8
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Informed Consent * adults, age ≥ 18 years, male or female patients * History of pain ≥ 3 months * Suffering from chronic pain * Intensity of pain rated ≥ 50 mm on VAS pain Exclusion Criteria: * Patients with an electrical or electronic implant. * Women who are pregnant, breastfeeding or planning to become pregnant * Patients who have already been treated with the cabin within the last 4 weeks. * Patients who are currently participating in other studies or who have participated in other studies in the last 30 days * Patients who have indicated their intention or who are suspected of intending to discontinue or discontinue therapy before the end of the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04818294